ERBB2 and aneurysmal bone cyst: General conclusions on thousands of HR+, HER2−, and ABC patients included in one extensive analysis confirmed not only significantly longer PFS (HR = 0.55; 95% CI, 0.50–0.59; p-value < 0.00001) but also established an improvement in OS (HR = 0.79; 95% CI, 0.67–0.93; p-value = 0.004), irrespective of menopausal status, age, race, the presence of visceral metastasis.